Harvard Apparatus Regenerative Technology Updates Patient Status By: Benzinga via Benzinga October 17, 2014 at 08:31 AM EDT Harvard Apparatus Regenerative Technology, Inc. (Nasdaq: HART), or HART, a clinical stage biotechnology company developing regenerated ... Read More >>